Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - COMMON STOCK
Common Stock ADAP - Adaptimmune Therapeutics plc
1.86 M
LAST VALUE
18.11%
2 YEAR CAGR
14.71%
5 YEAR CAGR
103.65%
10 YEAR CAGR